Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07296419 · ClinicalTrials.gov registry record · NA
Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
A NA study of Fetal Hypoxia and Fetal Acidemia, sponsored by Raydiant Oximetry.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07296419: Recruiting NA study of Fetal Hypoxia and Fetal Acidemia, sponsored by Raydiant Oximetry.
NCT07296419 is a NA study of Fetal Hypoxia and Fetal Acidemia that is actively recruiting participants, run by Raydiant Oximetry. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07296419, a NA study of Fetal Hypoxia and Fetal Acidemia, is actively recruiting participants, sponsored by Raydiant Oximetry.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to collect and compare fetal SpO2 waveforms and reference values to inform algorithm development for signal qualification and FSpO2 calculations. Subjects are women in labor.
Primary Outcome
Rate of device-related adverse events such as erythema or rash
Conditions Studied
Interventions
- DEVICE Fetal Pulse Oximetery
Study Locations (1)
Louisiana
- LSU Health Science Center-Shreveport - Shreveport
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-12-08 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT07296419 shows while recruiting
NCT07296419 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Fetal Hypoxia appearing as the primary indexed condition, and to 1 intervention - of which Fetal Pulse Oximetery is the first listed.
NCT07296419 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT07296419 about?
NCT07296419 is a clinical study titled "Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems". The objective of this study is to collect and compare fetal SpO2 waveforms and reference values to inform algorithm development for signal qualification and FSpO2 calculations. Subjects are women in labor.
What is the current status of trial NCT07296419?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-12-08. Estimated completion is 2026-04.
What conditions does trial NCT07296419 study?
This clinical trial studies the following conditions: Fetal Hypoxia, Fetal Acidemia.
What interventions are being tested in trial NCT07296419?
The interventions under investigation include: Fetal Pulse Oximetery (DEVICE).
Who is sponsoring clinical trial NCT07296419?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07296419 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Hypoxia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07296419's enrollment target sits among peer trials
15 1882nd of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI